Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01748162 · ClinicalTrials.gov registry record · Phase 3
Management of Recurrent Croup
A Phase 3 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT01748162: Clinical Trial Phase 3 study, sponsored by University of Michigan.
NCT01748162 is a Phase 3 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 10 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01748162, a Phase 3 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
Presently children who experience recurring croup symptoms receive a variety of treatments. This is because it is not clear which treatments may be best. Some children are given inhaled steroids (similar to what children with asthma use). Others are carefully watched and cautioned to avoid potential triggers (certain foods, environmental allergens, etc), and should episodes of croup recur they are treated with a short course of oral steroids. The purpose of this study is to compare two safe and clinically appropriate methods for treating recurrent croup, daily inhaled steroids versus observation with oral steroids on an as needed basis, to see if either is useful in preventing future episodes of croup.
Primary Outcome
Quantity of recurrent croup episodes experienced over a 1 year period by each participating subject.
Interventions
- DRUG Fluticasone
- DRUG Prednisolone IF needed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Why NCT01748162 stopped before completion
NCT01748162 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Fluticasone is the first listed.
NCT01748162 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01748162 about?
NCT01748162 is a clinical study titled "Management of Recurrent Croup". Presently children who experience recurring croup symptoms receive a variety of treatments. This is because it is not clear which treatments may be best. Some children are given inhaled steroids (similar to what children with asthma use). Others are carefully watched and cautioned to avoid potential...
What is the current status of trial NCT01748162?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2012-09. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01748162?
The interventions under investigation include: Fluticasone (DRUG), Prednisolone IF needed (DRUG).
Who is sponsoring clinical trial NCT01748162?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01748162's enrollment target sits among peer trials
10 1989th of 2000 higher than 9 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia